On the fly News and insights, exclusive to thefly.com

2019-11-19 10:13:23 AVGO Broadcom $322.53 / +11.58 (+3.72%) , MXL MaxLinear $20.14 / +0.3 (+1.51%) … 10:13 11/19/19 11/19 10:13 11/19/19 10:13	Fly Intel: Top five analyst upgrades Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Broadcom (AVGO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Craig Hettenbach saying while the stock is priced for risks associated with the Symantec deal, he has increased confidence in the company's software strategy amid what he sees as low expectations. 2. MaxLinear (MXL) upgraded to Buy from Hold at Needham with analyst N. Quinn Bolton saying the stock has "meaningfully underperformed" the broader Semiconductor index but believes that it is positioned to move higher, with market share gains expected "in microwave backhaul and the ramp of its 5G wireless transceiver." 3. Audentes Therapeutics (BOLD) upgraded to Outperform from In Line at Evercore ISI analyst Joshua Schimmer saying he is positive on the addition of new gene therapy programs for DMD and DM1, and expects it to move into the clinic next year with preliminary data by year end 2020. 4. Okta (OKTA) upgraded to Buy from Neutral at DA Davidson with analyst Andrew Nowinski saying while shares have declined 24% since the end of July, he believes the pullback represents a "good entry point" to get into one of the top Software-as-a-Service growth stocks. 5. AvalonBay (AVB) upgraded to Outperform from In Line at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. AVGO Broadcom $322.53 / +11.58 (+3.72%) MXL MaxLinear $20.14 / +0.3 (+1.51%) BOLD Boundless Bio $27.32 / +1.77 (+6.93%) OKTA Okta $124.81 / +3.6 (+2.97%) AVB AvalonBay $216.24 / +1.01 (+0.47%)	05 Dec 12 Dec 16 Dec

2019-11-19 10:13:23

AVGO

Broadcom

$322.53 / +11.58 (+3.72%)

, MXL

MaxLinear

$20.14 / +0.3 (+1.51%)

… 10:13

11/19/19

11/19

10:13

11/19/19

10:13

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Broadcom (AVGO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Craig Hettenbach saying while the stock is priced for risks associated with the Symantec deal, he has increased confidence in the company's software strategy amid what he sees as low expectations. 2. MaxLinear (MXL) upgraded to Buy from Hold at Needham with analyst N. Quinn Bolton saying the stock has "meaningfully underperformed" the broader Semiconductor index but believes that it is positioned to move higher, with market share gains expected "in microwave backhaul and the ramp of its 5G wireless transceiver." 3. Audentes Therapeutics (BOLD) upgraded to Outperform from In Line at Evercore ISI analyst Joshua Schimmer saying he is positive on the addition of new gene therapy programs for DMD and DM1, and expects it to move into the clinic next year with preliminary data by year end 2020. 4. Okta (OKTA) upgraded to Buy from Neutral at DA Davidson with analyst Andrew Nowinski saying while shares have declined 24% since the end of July, he believes the pullback represents a "good entry point" to get into one of the top Software-as-a-Service growth stocks. 5. AvalonBay (AVB) upgraded to Outperform from In Line at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

AVGO

Broadcom